Skip to content

The Toxic Legacy of Recreational Nitrous Oxide Use: A Systematic Review and Meta-Analysis of Multisystem Complications From Functional Vitamin B12 Deficiency

Richa Tikaria, A. Kapp, Samantha Shook, Ling Wang

Cureus May 1, 2026 DOI: 10.7759/cureus.108963 (opens in new tab)

Study at a glance

AI-extracted from the abstract
Characteristics Systematic review and meta-analysis Case report Peer reviewed
Sample size 1,809
Population Patients with nitrous oxide-induced vitamin B12 deficiency from case reports and case series
Measures homocysteine, methylmalonic acid, mean corpuscular volume, serum B12, hemoglobin, MRI, nerve conduction studies
Key findings Neurological symptoms, especially paresthesia, dominate nitrous oxide-induced B12 deficiency, with homocysteine and methylmalonic acid more frequently abnormal than serum B12, hemoglobin, or MCV. MRI and nerve conduction studies often show abnormalities even when hematologic markers are normal.

Abstract

Recreational nitrous oxide (N2O) use has increased in recent years and is an increasingly recognized cause of functional vitamin B12 deficiency with associated neurological and systemic complications. This systematic review and meta-analysis summarizes published case reports and case series describing the clinical, biochemical, and neurodiagnostic features of N2O-induced B12 deficiency. A comprehensive literature search of PubMed and Embase using the terms “nitrous oxide” and “B12” identified 458 publications. After exclusion of non-English and inaccessible articles, 257 studies were included, comprising 462 individual case reports and 1,291 patients from aggregated case series. Data extracted included demographics, duration of N2O exposure, clinical presentation, laboratory values (hemoglobin, mean corpuscular volume (MCV), serum B12, methylmalonic acid (MMA), and homocysteine), and findings from MRI and nerve conduction studies. A total of 1,809 patients were analyzed, including 1,753 with neuropathy and 56 with other presentations such as thrombosis, psychosis, or skin changes. Neurological symptoms were the most common manifestation, with paresthesia reported most frequently. In individual case reports, abnormal results were found in homocysteine (83.0%), MMA (68.4%), MCV (63.0%), serum B12 (55.8%), and hemoglobin (42.3%). Case series showed similar trends, with abnormalities most commonly observed in homocysteine (84.9%) and MMA (83.7%), followed by serum B12 (47.2%), hemoglobin (25.3%), and MCV (20.8%). MMA and homocysteine testing were performed in approximately 40% and 60% of patients, respectively. MRI and nerve conduction studies frequently demonstrated abnormalities even when hemoglobin, MCV, or serum B12 levels were normal. Significant differences in hemoglobin abnormalities and paresthesia presentation were observed between individual case reports and case series (p < 0.001). These findings indicate that N2O-induced functional B12 deficiency often presents with neurological symptoms without accompanying hematologic abnormalities and that MMA and homocysteine are more sensitive markers than serum B12 alone. Clinicians should consider N2O exposure and pursue appropriate metabolic testing in symptomatic patients, even in the presence of normal serum B12 or hemoglobin levels.

Citations in the library